Effects of Low Molecular Weight Heparin Versus Dabigatran on Platelet Aggregation in Patients With Stable Coronary Artery Disease

NCT02389582 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Coronary Disease

Interventions

DRUG: Dabigatran
DRUG: Enoxaparin

Sponsor

University of Sao Paulo General Hospital

Collaborators

[object Object]